Abstract: Genomic imprinting has been found to be involved in human physical development and several diseases. The DLK1-DIO3  imprinted domain is located on human chromosome 14 and contains paternally expressed protein-coding genes (DLK1 , RTL1 , DIO3 ) and numerous maternally expressed ncRNA genes (MEG3 , MEG8 , antisense RTL1 , miRNAs, piRNAs, and snoRNAs). Emerging evidence has implicated that dysregulation of the DLK1-DIO3  imprinted domain especially the imprinted ncRNAs is critical for tumor progressions. Multiple miRNAs and lncRNAs have been investigated in urological cancers, of which several are transcribed from this domain. In this review, we present current data about the associated miRNAs, lncRNAs, and piRNAs and the regulation of differentially methylated regions methylation status in the progression of urological cancers and preliminarily propose certain concepts about the potential regulatory networks involved in DLK1-DIO3  imprinted domain.
Keywords: ncRNAs, DLK1-DIO3  imprinted domain, epigenetics, regulatory network, urological cancers, DMRs , MEG3